Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- A8381 BIBR-1048Summary: Thrombin inhibitor
- A8170 Z-FA-FMKTarget: cysteine proteaseSummary: Cysteine proteases inhibitor
- B6689 Butabindide oxalateSummary: CCK-inactivating serine protease (tripeptidyl peptidase II) inhibitor
- B7719 TC-E 5006Summary: γ-secretase modulator
- A8189 PSI-62063 CitationTarget: HCV polymeraseSummary: Inhibitor of HCV RNA polymerase,potent and selective
- A8190 Semagacestat (LY450139)Summary: γ-secretase inhibitor
- B2204 Enalaprilat DihydrateSummary: angiotensin-converting enzyme (ACE) inhibitor
- B2208 RamiprilSummary: angiotensin-converting enzyme (ACE) inhibitor
- B7259 Macbecin ISummary: Hsp90 inhibitor
- B7703 TRC 051384Summary: HSP70 inducer